NEW YORK (TheStreet) -- Align Technology (ALGN) was gaining 4.6% to $56.04 after the International Trade Commission affirmed that ClearCorrect infringed five of the Invisalign maker's patents.
The ITC affirmed the Administrative Law Judge's Initial Determination that ClearCorrect infringed five patents related to software used to make transparent dental braces. The judge issued a cease-and-desist order against ClearCorrect, though the full orderand the commission's opinion are not yet available to the public or any parties involved.
Must read: Warren Buffett's 10 Favorite Growth Stocks
TheStreet Ratings team rates ALIGN TECHNOLOGY INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate ALIGN TECHNOLOGY INC (ALGN) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value."
Highlights from the analysis by TheStreet Ratings Team goes as follows: